NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 70 filers reported holding NEOS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 4.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,769,000 | -72.8% | 364,697 | -65.0% | 1.10% | -52.4% |
| Q2 2018 | $6,504,000 | -46.2% | 1,040,661 | -28.5% | 2.31% | -40.6% |
| Q1 2018 | $12,082,000 | +51.2% | 1,455,614 | +85.8% | 3.89% | +46.0% |
| Q4 2017 | $7,993,000 | +287.4% | 783,583 | +247.5% | 2.66% | +235.2% |
| Q3 2017 | $2,063,000 | – | 225,466 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,043,770 | $7,620,000 | 2.51% |
| Stonepine Capital Management, LLC | 565,100 | $4,125,000 | 2.23% |
| DAFNA Capital Management LLC | 209,873 | $1,532,000 | 1.09% |
| Ghost Tree Capital, LLC | 500,000 | $3,650,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,459,195 | $10,652,000 | 0.57% |
| PURA VIDA INVESTMENTS, LLC | 150,000 | $1,095,000 | 0.44% |
| J. Goldman & Co LP | 845,000 | $6,169,000 | 0.33% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 191,729 | $1,400,000 | 0.20% |
| Opaleye Management Inc. | 50,000 | $365,000 | 0.15% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 50,000 | $365,000 | 0.15% |